Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Insights into Praziquantel metabolism and potential enantiomeric CYP-mediated drug-drug interaction.

Vendrell-Navarro G, Scheible H, Lignet F, Burt H, Luepfert C, Marx A, Abla N, Swart P, Perrin D.

Drug Metab Dispos. 2020 Mar 19. pii: dmd.119.089888. doi: 10.1124/dmd.119.089888. [Epub ahead of print]

2.

Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation.

Villoslada P, Vila G, Colafrancesco V, Moreno B, Fernandez-Diez B, Vazquez R, Pertsovskaya I, Zubizarreta I, Pulido-Valdeolivas I, Messeguer J, Vendrell-Navarro G, Frade JM, López-Sánchez N, Teixido M, Giralt E, Masso M, Dugas JC, Leonoudakis D, Lariosa-Willingham KD, Steinman L, Messeguer A.

Neurotherapeutics. 2019 Jul;16(3):808-827. doi: 10.1007/s13311-019-00717-4.

PMID:
30815844
3.

The Pseudo Natural Product Myokinasib Is a Myosin Light Chain Kinase 1 Inhibitor with Unprecedented Chemotype.

Schneidewind T, Kapoor S, Garivet G, Karageorgis G, Narayan R, Vendrell-Navarro G, Antonchick AP, Ziegler S, Waldmann H.

Cell Chem Biol. 2019 Apr 18;26(4):512-523.e5. doi: 10.1016/j.chembiol.2018.11.014. Epub 2019 Jan 24.

PMID:
30686759
4.

Positional Scanning Synthesis of a Peptoid Library Yields New Inducers of Apoptosis that Target Karyopherins and Tubulin.

Vendrell-Navarro G, Rúa F, Bujons J, Brockmeyer A, Janning P, Ziegler S, Messeguer A, Waldmann H.

Chembiochem. 2015 Jul 27;16(11):1580-7. doi: 10.1002/cbic.201500169. Epub 2015 Jun 17.

PMID:
26010161
5.

Identification of the targets of biologically active small molecules using quantitative proteomics.

Vendrell-Navarro G, Brockmeyer A, Waldmann H, Janning P, Ziegler S.

Methods Mol Biol. 2015;1263:263-86. doi: 10.1007/978-1-4939-2269-7_21.

PMID:
25618352

Supplemental Content

Loading ...
Support Center